Back to News
Market Impact: 0.35

LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

Source: Nasdaq

Corporate EarningsHealthcare & BiotechCompany Fundamentals

LivaNova reported third-quarter 2026 net revenue of $393.1 million, up 9.9% year over year on a reported basis and 10.0% at constant currency. U.S. GAAP diluted EPS was $0.11; the available article text does not provide the comparison for EPS.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.30

Ticker Sentiment

LIVN0.50

More News

From AllMind Research

Browse all research